ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

BIO Biotest AG

41.60
0.00 (0.00%)
14:18:06 - Realtime Data
Share Name Share Symbol Market Type
Biotest AG TG:BIO Tradegate Ordinary Share
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 41.60 41.60 42.40 0.00 14:18:06

Bio-Rad Announces Agreement in Principle to Acquire MJ Research

02/06/2004 2:00pm

PR Newswire (US)


Biotest (TG:BIO)
Historical Stock Chart


From Jul 2019 to Jul 2024

Click Here for more Biotest Charts.
Bio-Rad Announces Agreement in Principle to Acquire MJ Research HERCULES, Calif., June 2 /PRNewswire-FirstCall/ -- Bio-Rad Laboratories, Inc. (Amex: BIO; BIOb), a multinational manufacturer and distributor of life science research products and clinical diagnostics, announced today that it has signed a binding letter agreement which sets forth certain principal terms for the acquisition by Bio-Rad of MJ GeneWorks, Inc., and its subsidiaries for approximately $47 million in cash plus the assumption of certain liabilities of those companies. MJ GeneWorks is the parent company of MJ Research, Inc. of Waltham, Massachusetts, a biotechnology company that specializes in thermal cycling instrumentation and reagents used to amplify DNA. The acquisition is subject to completion of a definitive purchase agreement and necessary government approvals. MJ Research, Inc. is a biotechnology company specializing in premium instruments and consumables used in modern biological research. MJ Research pioneered the use of Peltier-effect technology and has introduced a number of other innovations in the thermal-cycling field. MJ Research employs approximately 300 employees. Bio-Rad Laboratories, Inc. (http://www.bio-rad.com/) is a multinational manufacturer and distributor of life science research products and clinical diagnostics. It is based in Hercules, California, and serves more than 70,000 research and industry customers worldwide through a network of more than 30 wholly owned subsidiary offices. Various statements made within this press release may constitute "forward-looking statements" for purposes of the Securities and Exchange Commission's "safe harbor" provisions under the Private Securities Litigation Reform Act of 1995 and Rule 3b-6 under the Securities Exchange Act of 1934. The forward-looking statements contained herein involve risks and uncertainties that could cause results to differ materially from the Company's expectations. DATASOURCE: Bio-Rad Laboratories, Inc. CONTACT: Christine Tsingos, Vice President and Chief Financial Officer, or Ron Hutton, Treasurer, both of Bio-Rad Laboratories, Inc., +1-510-724-7000, or Web site: http://www.bio-rad.com/

Copyright

1 Year Biotest Chart

1 Year Biotest Chart

1 Month Biotest Chart

1 Month Biotest Chart